Skip to main content


How I Read Cancer Imaging Studies: The Master Class Series

Surprisingly, in contrast to the literature regarding the outcomes of imaging, the methods that underpin the generation of a report and how to communicate the findings cogently to referring clinicians remains something of a “black box”.

This series of articles appearing in Cancer Imaging showcases experts in various modalities detailing their approach to reporting scans in particular disease settings. We hope that you will be excited to discover this data, which has traditionally been locked into the brains of experts and only intermittently shared with their own direct trainees or alternatively, at often expensive masterclass presentations.

Read the introductory Editorial for ‘How I read cancer imaging studies: the master class series’ written by Prof Rodney Hicks, Editor-in-Chief of Cancer Imaging.


  1. Content type: Review

    Technical advances in imaging are well demonstrated by MRI (Magnetic Resonance Imaging) and PET (Positron Emission Tomography). Excellent anatomical detail and a lack of ionising radiation make MRI the standar...

    Authors: Arian Lasocki and Rodney J. Hicks

    Citation: Cancer Imaging 2019 19:57

    Published on:

  2. Content type: Review

    The Liver Imaging Reporting and Data System (LI-RADS) standardizes the interpretation and reporting of imaging examinations in patients at risk for hepatocellular carcinoma (HCC). For focal liver observations ...

    Authors: Wolfgang Schima and Jay Heiken

    Citation: Cancer Imaging 2018 18:14

    Published on:

  3. Content type: Review

    PET/CT plays an important role in the diagnosis, staging and management of many pediatric malignancies. The techniques for performing PET/CT examinations in children have evolved, with increasing attention foc...

    Authors: Gabrielle C. Colleran, Neha Kwatra, Leah Oberg, Frederick D. Grant, Laura Drubach, Michael J. Callahan, Robert D. MacDougall, Frederic H. Fahey and Stephan D. Voss

    Citation: Cancer Imaging 2017 17:28

    Published on:

  4. Content type: Review

    Over the last decade, 18F-fluorocholine positron emission tomography/computed tomography (FCH-PET/CT) has gained in popularity for the staging and restaging of patients with prostate cancer (PCa). However, despit...

    Authors: Jean-Mathieu Beauregard and Alexis Beaulieu

    Citation: Cancer Imaging 2016 16:41

    Published on:

  5. Content type: Review

    18F-fluorodeoxyglucose (FDG) PET/CT is a pivotal imaging modality for cancer imaging, assisting diagnosis, staging of patients with newly diagnosed malignancy, restaging following therapy...

    Authors: Michael S. Hofman and Rodney J. Hicks

    Citation: Cancer Imaging 2016 16:35

    Published on:

  6. Content type: Review

    Liver tumours are fortunately rare in children. Benign tumours such as haemangiomas and cystic mesenchymal hamartomas are typically seen in infancy, often before 6 months of age. After that age, malignant hepa...

    Authors: Susan C. Shelmerdine, Derek J. Roebuck, Alexander J. Towbin and Kieran McHugh

    Citation: Cancer Imaging 2016 16:21

    Published on:

  7. Content type: Review

    Recently, positron emission tomography (PET) imaging using PSMA-ligands has gained high attention as a promising new radiotracer in patients with prostate cancer (PC). Several studies promise accurate staging ...

    Authors: Isabel Rauscher, Tobias Maurer, Wolfgang P. Fendler, Wieland H. Sommer, Markus Schwaiger and Matthias Eiber

    Citation: Cancer Imaging 2016 16:14

    Published on:

  8. Content type: Review

    Endometrial cancer is the most common malignancy of the female pelvis. New concepts in endometrial cancer treatment emphasize the value of MRI as a major predictor of lymph node metastasis and tumour recurrenc...

    Authors: Matthias Meissnitzer and Rosemarie Forstner

    Citation: Cancer Imaging 2016 16:11

    Published on: